These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 11815296)
1. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease. Portis T; Cooper L; Dennis P; Longnecker R Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease. Cooper L; Longnecker R Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506 [TBL] [Abstract][Full Text] [Related]
3. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency. Rechsteiner MP; Bernasconi M; Berger C; Nadal D Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas. Incrocci R; McCormack M; Swanson-Mungerson M J Gen Virol; 2013 May; 94(Pt 5):1127-1133. PubMed ID: 23303827 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Portis T; Longnecker R Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852 [TBL] [Abstract][Full Text] [Related]
6. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Pang MF; Lin KW; Peh SC Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921 [TBL] [Abstract][Full Text] [Related]
7. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. Ikeda M; Ikeda A; Longnecker R J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3. Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904 [TBL] [Abstract][Full Text] [Related]
9. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection. Price AM; Messinger JE; Luftig MA J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Longnecker R Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156 [TBL] [Abstract][Full Text] [Related]
13. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. Konishi K; Maruo S; Kato H; Takada K J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890 [TBL] [Abstract][Full Text] [Related]
14. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function. Merchant M; Swart R; Katzman RB; Ikeda M; Ikeda A; Longnecker R; Dykstra ML; Pierce SK Int Rev Immunol; 2001; 20(6):805-35. PubMed ID: 11913951 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815 [TBL] [Abstract][Full Text] [Related]
16. Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases. Swanson-Mungerson M; Ikeda M; Lev L; Longnecker R; Portis T J Antimicrob Chemother; 2003 Aug; 52(2):152-4. PubMed ID: 12837743 [No Abstract] [Full Text] [Related]
17. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1. Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773 [TBL] [Abstract][Full Text] [Related]
18. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential. Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657 [TBL] [Abstract][Full Text] [Related]
19. Latent Membrane Protein 2 (LMP2). Cen O; Longnecker R Curr Top Microbiol Immunol; 2015; 391():151-80. PubMed ID: 26428374 [TBL] [Abstract][Full Text] [Related]